国际系统性红斑狼疮起始队列中损伤累积的经济评估:多状态模型方法
该研究基于SLICC起始队列中11国33中心的1687例SLE患者,采用多状态模型估算不同SDI损伤状态相关的年均费用与10年累积费用。结果显示SDI≥5者年均费用为22006加元,SDI为0者为1833加元;10年累积费用分别为189073加元与21713加元,高损伤组约低损伤组的9倍。
要点
- SDI≥5者年均费用22006加元,SDI为0者1833加元。
- SDI≥5者10年累积费用189073加元,SDI为0者21713加元。
- 高SDI组10年累积费用约为低SDI组的9倍。
核心结论
- SDI最高组10年累积费用约为最低组的9倍。
- 结合损伤轨迹与年度费用可估算未来费用,有助于评估新疗法的成本效果。
研究设计与样本
- 国际多中心起始队列研究,纳入11国33中心在诊断15个月内的SLE患者。
- 共1687例患者,88.7%为女性,49.0%为白人,诊断时平均年龄34.6±13.3岁,平均随访8.9年(范围0.6-18.5年)。
- 收集人口学、疾病活动度、SDI损伤、住院、用药、透析及选定操作的年数据。
- 采用多状态模型,将各SDI状态年度费用乘以预期状态持续时间估算10年累积费用(加元)。
主要发现
- SDI≥5者年均费用为22006加元(95%CI 16662, 27350),SDI为0者为1833加元(95%CI 1134, 2532)。
- 10年区间开始时SDI≥5者10年累积费用为189073加元(95%CI 142318, 235827),SDI为0者为21713加元(95%CI 13639, 29788)。
关键数值与推荐
- 年均费用:SDI≥5为22006加元(95%CI 16662, 27350),SDI为0为1833加元(95%CI 1134, 2532)。
- 10年累积费用:SDI≥5为189073加元(95%CI 142318, 235827),SDI为0为21713加元(95%CI 13639, 29788)。
临床怎么用
- 可将SDI损伤状态用于估算SLE患者未来医疗费用。
- 费用数据可为评估新疗法成本效果提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There is a paucity of data regarding health care costs associated with damage accrual in systemic lupus erythematosus. The present study was undertaken to describe costs associated with damage states across the disease course using multistate modeling. METHODS: Patients from 33 centers in 11 countries were enrolled in the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort within 15 months of diagnosis. Annual data on demographics, disease activity, damage (SLICC/American College of Rheumatology Damage Index [SDI]), hospitalizations, medications, dialysis, and selected procedures were collected. Ten-year cumulative costs (Canadian dollars) were estimated by multiplying annual costs associated with each SDI state by the expected state duration using a multistate model. RESULTS: A total of 1,687 patients participated; 88.7% were female, 49.0% were white, mean ± SD age at diagnosis was 34.6 ± 13.3 years, and mean time to follow-up was 8.9 years (range 0.6-18.5 years). Mean annual costs were higher for those with higher SDI scores as follows: $22,006 (Canadian) (95% confidence interval [95% CI] $16,662, $27,350) for SDI scores ≥5 versus $1,833 (95% CI $1,134, $2,532) for SDI scores of 0. Similarly, 10-year cumulative costs were higher for those with higher SDI scores at the beginning of the 10-year interval as follows: $189,073 (Canadian) (95% CI $142,318, $235,827) for SDI scores ≥5 versus $21,713 (95% CI $13,639, $29,788) for SDI scores of 0. CONCLUSION: Patients with the highest SDI scores incur 10-year cumulative costs that are ~9-fold higher than those with the lowest SDI scores. By estimating the damage trajectory and incorporating annual costs, data on damage can be used to estimate future costs, which is critical knowledge for evaluating the cost-effectiveness of novel therapies.
引用
- Barber MRW, Hanly JG, Su L, et al. Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach. Arthritis Care Res (Hoboken). 2020. PMID: 31609532. doi:10.1002/acr.24092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。